How i Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

Patrick M. Reagan; Sattva S. Neelapu

doi:10.1200/JCO.20.01616

How i Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

Patrick M. Reagan, Sattva S. Neelapu

Lymphoma-Myeloma

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Original language	English (US)
Pages (from-to)	456-466
Number of pages	11
Journal	Journal of Clinical Oncology
Volume	39
Issue number	5
DOIs	https://doi.org/10.1200/JCO.20.01616
State	Published - Feb 10 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.20.01616

Cite this

@article{272ec8cc8e5848d5856a958777d496db,

title = "How i Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies",

author = "Reagan, {Patrick M.} and Neelapu, {Sattva S.}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = feb,

day = "10",

doi = "10.1200/JCO.20.01616",

language = "English (US)",

volume = "39",

pages = "456--466",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "5",

}

TY - JOUR

T1 - How i Manage

T2 - Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

AU - Reagan, Patrick M.

AU - Neelapu, Sattva S.

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/2/10

Y1 - 2021/2/10

UR - http://www.scopus.com/inward/record.url?scp=85102040805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102040805&partnerID=8YFLogxK

U2 - 10.1200/JCO.20.01616

DO - 10.1200/JCO.20.01616

M3 - Review article

C2 - 33434058

AN - SCOPUS:85102040805

SN - 0732-183X

VL - 39

SP - 456

EP - 466

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 5

ER -

How i Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this